These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28012891)

  • 1. Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs.
    Brunden KR; Lee VM; Smith AB; Trojanowski JQ; Ballatore C
    Neurobiol Dis; 2017 Sep; 105():328-335. PubMed ID: 28012891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.
    Brunden KR; Trojanowski JQ; Smith AB; Lee VM; Ballatore C
    Bioorg Med Chem; 2014 Sep; 22(18):5040-9. PubMed ID: 24433963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments.
    Trojanowski JQ; Smith AB; Huryn D; Lee VM
    Expert Opin Pharmacother; 2005 May; 6(5):683-6. PubMed ID: 15934894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).
    Magen I; Gozes I
    Neuropeptides; 2013 Dec; 47(6):489-95. PubMed ID: 24210139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Naturally Occurring Small Molecule Microtubule-Stabilizing Agents: A Potential Tactic for CNS-Directed Therapies.
    Ballatore C; Brunden KR; Trojanowski JQ; Lee VM; Smith AB
    ACS Chem Neurosci; 2017 Jan; 8(1):5-7. PubMed ID: 28095679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal Transport and Neurodegeneration: How Marine Drugs Can Be Used for the Development of Therapeutics.
    White JA; Banerjee R; Gunawardena S
    Mar Drugs; 2016 May; 14(5):. PubMed ID: 27213408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies.
    Brunden KR; Yao Y; Potuzak JS; Ferrer NI; Ballatore C; James MJ; Hogan AM; Trojanowski JQ; Smith AB; Lee VM
    Pharmacol Res; 2011 Apr; 63(4):341-51. PubMed ID: 21163349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microtubule acetylation dyshomeostasis in Parkinson's disease.
    Naren P; Samim KS; Tryphena KP; Vora LK; Srivastava S; Singh SB; Khatri DK
    Transl Neurodegener; 2023 May; 12(1):20. PubMed ID: 37150812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice.
    Zhang B; Carroll J; Trojanowski JQ; Yao Y; Iba M; Potuzak JS; Hogan AM; Xie SX; Ballatore C; Smith AB; Lee VM; Brunden KR
    J Neurosci; 2012 Mar; 32(11):3601-11. PubMed ID: 22423084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of taxoid and nontaxoid site microtubule-stabilizing agents on axonal transport of mitochondria in untransfected and ECFP-htau40-transfected rat cortical neurons in culture.
    Das V; Sim DA; Miller JH
    J Neurosci Res; 2014 Sep; 92(9):1155-66. PubMed ID: 24788108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function.
    Field JJ; Kanakkanthara A; Miller JH
    Bioorg Med Chem; 2014 Sep; 22(18):5050-9. PubMed ID: 24650703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer's Disease and Related Tauopathies.
    Kovalevich J; Cornec AS; Yao Y; James M; Crowe A; Lee VM; Trojanowski JQ; Smith AB; Ballatore C; Brunden KR
    J Pharmacol Exp Ther; 2016 May; 357(2):432-50. PubMed ID: 26980057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau and axonopathy in neurodegenerative disorders.
    Higuchi M; Lee VM; Trojanowski JQ
    Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubule stabilization by peloruside A and paclitaxel rescues degenerating neurons from okadaic acid-induced tau phosphorylation.
    Das V; Miller JH
    Eur J Neurosci; 2012 Jun; 35(11):1705-17. PubMed ID: 22594877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies.
    Ballatore C; Brunden KR; Trojanowski JQ; Lee VM; Smith AB; Huryn DM
    Curr Top Med Chem; 2011; 11(3):317-30. PubMed ID: 21320060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule-modulating Agents in the Fight Against Neurodegeneration: Will it ever Work?
    Soliman A; Bakota L; Brandt R
    Curr Neuropharmacol; 2022; 20(4):782-798. PubMed ID: 34852744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications.
    Guo W; Stoklund Dittlau K; Van Den Bosch L
    Semin Cell Dev Biol; 2020 Mar; 99():133-150. PubMed ID: 31542222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microtubules in health and degenerative disease of the nervous system.
    Matamoros AJ; Baas PW
    Brain Res Bull; 2016 Sep; 126(Pt 3):217-225. PubMed ID: 27365230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KymoAnalyzer: a software tool for the quantitative analysis of intracellular transport in neurons.
    Neumann S; Chassefeyre R; Campbell GE; Encalada SE
    Traffic; 2017 Jan; 18(1):71-88. PubMed ID: 27770501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.